NAVBQ - NAVIDEA BIOPHARMACEUTICALS, INC.
0.08
0.080 100.000%
Share volume: 0
Last Updated: 10-05-2023
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
22%
Profitability
0%
Dept financing
50%
Liquidity
13%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.6%
Return on assets
-4.77%
Return on sales
-447.09%
Return on invested capital
-122.71%
Total debt ratio
284.55%
Debt ratio change over timeo
0%
Current Ratio
1.44%
Quick Ratio
0.81%
Cash Position Ratio
0.6%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.52%
Return on assets
-13.47%
Return on sales
-568.75%
Return on invested capital
-153.41%
Total debt ratio
187.15%
Debt ratio change over timeo
0%
Current Ratio
1.76%
Quick Ratio
1.15%
Cash Position Ratio
0.73%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-10%
Return on assets
-10.4%
Return on sales
-1050.92%
Return on invested capital
-98.71%
Total debt ratio
32.11%
Debt ratio change over time
0%
Current Ratio
2.58%
Quick Ratio
0%
Cash Position Ratio
0.79%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NAVBQ | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | -7.6% | -176.74% | -7.74% | -0.57% |
| Return on assets | -4.77% | 6.25% | 5.11% | 1.02% |
| Return on sales | -447.09% | 20.77% | 16.76% | 4.64% |
| Return on invested capital | -122.71% | -40.52% | 7.04% | -0.66% |
| Profitability | 0% | 50% | 66% | 35% |
| Total debt ratio | 284.55% | 102.82% | 137.99% | 47.62% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 9% | 12% | 4% |
| Current Ratio | 1.76% | 0.91% | 2.78% | 7.15% |
| Quick Ratio | 1.15% | 0.73% | 2.31% | 6.43% |
| Cash Position Ratio | 0.73% | 0.17% | 1.25% | 5.46% |
| Liquididy | 11% | 7% | 24% | 75% |
| Short-term ratios | NAVBQ | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | -9.52% | -96.34% | -8.8% | -0.64% |
| Return on assets | -13.47% | 6.16% | 5.2% | 1.12% |
| Return on sales | -568.75% | 20.68% | 16.83% | 4.63% |
| Return on invested capital | -153.41% | -28.64% | 7.79% | -0.73% |
| Profitability | 0% | 50% | 66% | 35% |
| Total debt ratio | 187.15% | 104.99% | 135.61% | 47.59% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 14% | 18% | 6% |
| Current Ratio | 1.76% | 0.91% | 2.78% | 7.15% |
| Quick Ratio | 1.15% | 0.73% | 2.31% | 6.43% |
| Cash Position Ratio | 0.73% | 0.17% | 1.25% | 5.46% |
| Liquididy | 14% | 7% | 24% | 75% |